Workflow
珍药商品
icon
Search documents
珍宝岛跌2.05%,成交额4124.41万元,主力资金净流出652.15万元
Xin Lang Cai Jing· 2025-09-15 02:54
珍宝岛所属申万行业为:医药生物-中药Ⅱ-中药Ⅲ。所属概念板块包括:黑龙江自贸区、抗流感、医药 电商、中药、中盘等。 截至7月18日,珍宝岛股东户数2.15万,较上期增加2.34%;人均流通股43744股,较上期减少2.29%。 2025年1月-6月,珍宝岛实现营业收入7.14亿元,同比减少57.05%;归母净利润-7828.99万元,同比减少 119.90%。 分红方面,珍宝岛A股上市后累计派现13.02亿元。近三年,累计派现3.56亿元。 责任编辑:小浪快报 9月15日,珍宝岛盘中下跌2.05%,截至10:40,报11.96元/股,成交4124.41万元,换手率0.36%,总市值 112.54亿元。 资金流向方面,主力资金净流出652.15万元,大单买入707.23万元,占比17.15%,卖出1359.38万元,占 比32.96%。 珍宝岛今年以来股价涨4.45%,近5个交易日涨0.93%,近20日跌3.31%,近60日涨7.46%。 资料显示,黑龙江珍宝岛药业股份有限公司位于黑龙江省哈尔滨市平房区烟台一路8号,成立日期1996 年10月28日,上市日期2015年4月24日,公司主营业务涉及以高端中药制剂为 ...
珍宝岛涨2.07%,成交额9006.89万元,主力资金净流入55.54万元
Xin Lang Zheng Quan· 2025-09-12 06:29
Core Viewpoint - The stock price of Zhenbaodao has shown a mixed performance in recent months, with a year-to-date increase of 7.69% and a notable drop in revenue and net profit for the first half of 2025 [2][3]. Company Overview - Zhenbaodao Pharmaceutical Co., Ltd. is located in Harbin, Heilongjiang Province, and was established on October 28, 1996. It was listed on April 24, 2015. The company specializes in the research, production, and sales of high-end traditional Chinese medicine [2]. - The main business revenue composition includes: 84.82% from the sale of proprietary Chinese medicine, 7.13% from purchased medicinal materials, 5.11% from purchased pharmaceuticals, 2.51% from other sources, 0.35% from rental income, and 0.07% from interest income [2]. Stock Performance - As of September 12, Zhenbaodao's stock price increased by 2.07%, reaching 12.33 CNY per share, with a total market capitalization of 11.602 billion CNY. The trading volume was 90.0689 million CNY, with a turnover rate of 0.79% [1]. - Year-to-date, the stock price has increased by 7.69%, with a 4.14% rise over the last five trading days, a slight decline of 0.16% over the last 20 days, and an increase of 11.18% over the last 60 days [2]. Financial Performance - For the first half of 2025, Zhenbaodao reported an operating income of 714 million CNY, a significant decrease of 57.05% year-on-year. The net profit attributable to the parent company was -78.2899 million CNY, reflecting a year-on-year decrease of 119.90% [2]. - Since its A-share listing, Zhenbaodao has distributed a total of 1.302 billion CNY in dividends, with 356 million CNY distributed over the past three years [3]. Shareholder Information - As of July 18, the number of shareholders for Zhenbaodao was 21,500, an increase of 2.34% from the previous period. The average circulating shares per person decreased by 2.29% to 43,744 shares [2].